← Back to Search

Other

Tobacco Use Treatment Service and Varenicline Management for Tobacco Use

N/A
Recruiting
Research Sponsored by Abramson Cancer Center at Penn Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 day follow-up assessment
Awards & highlights

Study Summary

This trial will study whether adding a standing order for prescription and management of varenicline within the workflow for cancer patients who smoke will increase the rate of them using tobacco treatment.

Who is the study for?
This trial is for healthcare providers in Medical and Radiation Oncology at ACC, Pennsylvania with prescribing authority. They must be non-smokers, have treated a tobacco use disorder patient within the last month, speak English, and consent to participate.Check my eligibility
What is being tested?
The study tests if adding a standing order for varenicline (a medication to help quit smoking) improves Tobacco Use Treatment rates among cancer patients who smoke compared to just the standard care without this added protocol.See study design
What are the potential side effects?
While side effects are not detailed here as it focuses on provider behavior rather than patient outcomes, varenicline can typically cause nausea, sleep disturbances, headaches, and sometimes mood changes or cardiovascular events.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 day follow-up assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 day follow-up assessment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Engagement Rate
Secondary outcome measures
Abstinence Rate
Assessment Rate
Prescription Rate
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Tobacco Use Treatment Service + Varenicline ManagementExperimental Treatment1 Intervention
TUTS + Varenicline Management
Group II: Usual CareActive Control1 Intervention
TUT Service Only

Find a Location

Who is running the clinical trial?

Abramson Cancer Center at Penn MedicineLead Sponsor
387 Previous Clinical Trials
145,482 Total Patients Enrolled
2 Trials studying Tobacco Use
2,646 Patients Enrolled for Tobacco Use
University of PennsylvaniaOTHER
2,002 Previous Clinical Trials
42,880,817 Total Patients Enrolled
9 Trials studying Tobacco Use
4,178 Patients Enrolled for Tobacco Use

Media Library

Tobacco Use Treatment Service and Varenicline Management (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04738643 — N/A
Tobacco Use Research Study Groups: Usual Care, Tobacco Use Treatment Service + Varenicline Management
Tobacco Use Clinical Trial 2023: Tobacco Use Treatment Service and Varenicline Management Highlights & Side Effects. Trial Name: NCT04738643 — N/A
Tobacco Use Treatment Service and Varenicline Management (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04738643 — N/A
Tobacco Use Patient Testimony for trial: Trial Name: NCT04738643 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings available for participation in this research?

"That is correct. Perusing the information published on clinicaltrials.gov unveils that, as of September 28th 2022, this medical research project has been looking for volunteers to participate in it since June 28th: 52 participants are needed across 1 site."

Answered by AI

What is the recruitment rate for this research project?

"Affirmative. According to clinicaltrials.gov, this study commenced on June 28th 2022 and is currently seeking participants for recruitment. A total of 52 volunteers are needed at a single medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Maryland
What site did they apply to?
University of Pennsylvania
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
2

Why did patients apply to this trial?

To learn more about my smoking addiction.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Improving Tobacco Treatment Rates for Cancer Patients Who Smoke
2022. "Improving Tobacco Treatment Rates for Cancer Patients Who Smoke". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04738643.
All > Chantix
~2 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top